ursodeoxycholic acid has been researched along with Hypertension, Pulmonary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amuro, H; Ito, T; Nishizawa, T; Nomura, S; Ozaki, Y; Son, Y; Tamaki, T; Tanaka, A | 1 |
1 other study(ies) available for ursodeoxycholic acid and Hypertension, Pulmonary
Article | Year |
---|---|
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.
Topics: Aged; Bosentan; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Liver Function Tests; Middle Aged; Sulfonamides; Ursodeoxycholic Acid | 2014 |